superph app for android
Austin, Dec. 08, 2024 (GLOBE NEWSWIRE) -- The S&S Insider report indicates that, “ The Downstream Processing Market was valued at USD 29.35 Billion in 2023 and is projected to reach USD 99.64 Billion by 2032, growing at a compound annual growth rate (CAGR) of 14.60% from 2024 to 2032. ” Accelerating Growth of the Downstream Processing Market The downstream processing market is experiencing rapid expansion, fueled by the surging demand for biopharmaceuticals such as vaccines, monoclonal antibodies, and enzymes. This growth is driven by the rising prevalence of chronic diseases and advancements in biotechnology, which have spurred the development of biologics. With global pharmaceutical industry revenues reaching approximately USD 1.6 trillion in 2023, biopharmaceuticals have emerged as a significant and fast-growing segment. Downstream processing is pivotal in ensuring the efficient purification and recovery of these complex products, promoting further innovation in the field. This innovation is reflected in the adoption of advanced technologies like single-use systems, membrane chromatography, and continuous processing. By Q1 2023, over 100 approved gene, cell, and RNA therapies, alongside 3,700 therapies in development, underscored the rising need for scalable solutions. These advancements enhance operational efficiency, reduce costs, and support the increasing global demand for biologics. Download PDF Sample of Downstream Processing Market @ https://www.snsinsider.com/sample-request/2618 Key Players: Merck KGaA (MilliporeSigma) (Viresolve Barrier Filters, ProSep Ultra Plus Protein A Resin) Sartorius Stedim Biotech S.A (Sartobind Membrane Adsorbers, Sartoflow Advanced Systems) Thermo Fisher Scientific Inc. (POROS Chromatography Resins, CaptureSelect Affinity Ligands) Danaher Corporation (Pall Allegro MVP Single-Use System, Cytiva ReadyToProcess Columns) Repligen (OPUS Pre-packed Columns, XCell ATF Systems) 3M Company (Zeta Plus Depth Filters, Emphaze AEX Hybrid Purifiers) Boehringer Ingelheim International GmbH (BIHEX Process Solutions, Biopharmaceutical Contract Services) Corning Corporation (Corning CellCube Systems, X-Series Hollow Fiber Filters) Lonza Group Ltd (Centrifuge Systems, Viral Clearance Services) Dover Corporation (Quattroflow Diaphragm Pumps, Maag Industrial Filtration Solutions) Asahi Kasei (Planova Virus Filters, Microza UF Membranes) Eppendorf AG (Centrifuge 5910 R, BioFlo Bioprocess Controllers) Finesse Solutions Inc. (Thermo Fisher Subsidiary) (SmartVessel Bioreactor, G3Lab Universal Controllers) Purolite Life Sciences (Praesto Protein A Resins, Chromalite Ion Exchange Resins) Tosoh Bioscience (TOYOPEARL Protein A Resins, TSKgel Chromatography Columns) Novasep (BioSC Chromatography Systems, Prochrom Bio Columns) MilliporeSigma (a subsidiary of Merck KGaA) (Durapore Filters, Chromabolt Pre-packed Columns) Waters Corporation (PATROL UPLC Process Analyzer, AutoPurification Systems) PerkinElmer Inc. (LabChip GXII Microfluidics System, QSight 420 Mass Spectrometer) Bio-Rad Laboratories, Inc. (UNOsphere Chromatography Resins, NGC Chromatography Systems) Avantor (VWR) (J.T.Baker High Purity Solvents, Arium Sterile Filtration Units) Spectrum Labs (Repligen subsidiary) (KrosFlo TFF Systems, Hollow Fiber TFF Modules) Meissner Filtration Products (UltraCap Depth Filters, FlexGro Single-Use Assemblies) Downstream Processing Market Report Scope: If You Need Any Customization on Downstream Processing Market Report, I nquire Now @ https://www.snsinsider.com/enquiry/2618 By Application , Antibiotics Dominate While Antibodies Drive Rapid Growth in Downstream Processing Market In 2023, the Antibiotic Production segment captured 34% of the downstream processing market revenue, driven by global demand to combat bacterial infections. Their widespread application in healthcare and agriculture, coupled with mature manufacturing practices, ensures large-scale production and steady revenues. Cost-effective purification methods and antibiotics' essential role in public health further solidify this segment's dominance. The Antibodies Production segment is expected to grow at a CAGR of 16.51% from 2024 to 2032, fueled by rising demand for monoclonal antibodies and biosimilars to treat cancer and autoimmune diseases. Innovations in scalable downstream technologies, such as chromatography and single-use systems, and a robust pipeline of therapies are accelerating growth, highlighting the segment’s expanding prominence in biopharma. By Technique , Chromatography Leads While Solid-Liquid Separation Drives Future Growth In 2023, the Purification By Chromatography segment accounted for 42% of the downstream processing market revenue, owing to its unmatched ability to deliver high-purity biomolecules. Its adaptability for diverse biopharmaceuticals, including monoclonal antibodies and vaccines, has positioned it as a vital industry tool. Ongoing technological advancements have further solidified its role as the most reliable purification method. The Solid-Liquid Separation segment is poised to grow at the fastest CAGR of 16.99% from 2024 to 2032, driven by rising demand for efficient filtration and centrifugation solutions. Its critical role in biologics and cell therapy production, coupled with a shift toward sustainable and cost-effective manufacturing, drives innovation. These factors underline its importance in meeting the evolving needs of the biopharma sector. North America Dominates, Asia Pacific Drives Rapid Growth In 2023, North America accounted for 36% of the downstream processing market revenue, led by its strong biopharmaceutical industry and advanced R&D infrastructure. Substantial investments in manufacturing technologies and the presence of major market players have reinforced its dominance. High demand for biologics and favorable regulatory support further cement its leadership. The Asia Pacific region is set to grow at the fastest CAGR of 16.68% from 2024 to 2032, driven by increasing biopharma investments and expanding healthcare infrastructure. Government initiatives promoting local biomanufacturing and cost-efficient production capabilities are key growth drivers. The region's rising demand for biologics and biosimilars underscores its growing role in the global market. Buy Full Research Report on Downstream Processing Market 2024-2032 @ https://www.snsinsider.com/checkout/2618 Key Developments in the Downstream Processing Market On November 21, 2024, Sartorius Stedim Biotech inaugurated its Center for Bioprocess Innovation in Marlborough, USA, focusing on cell and gene therapy manufacturing with GMP suites set to open in 2025. On November 7, 2024, Thermo Fisher Scientific announced the construction of a 10,000-square-foot Bioprocess Design Center in Hyderabad, India, to advance biotherapeutics manufacturing, opening in early 2025. Table of Contents – Major Key Points 1. Introduction Market Definition Scope (Inclusion and Exclusions) Research Assumptions 2. Executive Summary Market Overview Regional Synopsis Competitive Summary 3. Research Methodology Top-Down Approach Bottom-up Approach Data Validation Primary Interviews 4. Market Dynamics Impact Analysis Market Driving Factors Analysis PESTLE Analysis Porter’s Five Forces Model 5. Statistical Insights and Trends Reporting Regulatory Approvals Technological Adoption Rates Cost Contributions Regulatory Approvals 6. Competitive Landscape List of Major Companies, By Region Market Share Analysis, By Region Product Benchmarking Strategic Initiatives Technological Advancements Market Positioning and Branding 7. Downstream Processing Market Segmentation, by Application 8. Downstream Processing Market Segmentation, by Product 9. Downstream Processing Market Segmentation, by Technique 10. Regional Analysis 11. Company Profiles 12. Use Cases and Best Practices 13. Conclusion Speak with O ur E xpert A nalyst T oday to G ain D eeper I nsights @ https://www.snsinsider.com/request-analyst/2618 [For more information or need any customization research mail us at info@snsinsider.com ] About Us: S&S Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Rutgers is in flux heading into its bowl game. The Scarlet Knights (7-5, 4-5) learned on Sunday that they will participate in the Rate Bowl , where they will face Kansas State (8-4, 5-4) at Chase Field in Phoenix, Arizona. Scheduled for December 26th, the contest is coming up quick, leaving Rutgers with little time to figure out its most pressing staff situation.None
Oklahoma State hires Todd Grantham as defensive coordinatorBlues supporters also sang the name of head coach Maresca during the closing stages of an emphatic success sealed by goals from Axel Disasi, Christopher Nkunku, Noni Madueke, Cole Palmer and substitute Jadon Sancho. Bottom club Southampton briefly levelled through Joe Aribo but were a man down from the 39th minute after captain Jack Stephens was sent off for pulling the hair of Marc Cucurella. Chelsea, who have endured an underwhelming period since Todd Boehly’s consortium bought the club in 2022, climbed above Arsenal and into second place on goal difference, seven points behind leaders Liverpool. “It was a very good feeling, especially because you can see that they are happy, that is our target,” Maresca said of the atmosphere in the away end. “We work every day to keep them happy and tonight was a very good feeling, especially the one that they can see that Chelsea’s back. This is an important thing.” Maresca rotated his squad in Hampshire, making seven changes following Sunday’s impressive 3-0 win over Aston Villa. Following a sloppy start, his side, who stretched their unbeaten run to six top-flight games, could easily have won by more as they hit the woodwork three times, in addition to squandering a host of chances. “I’m very happy with the five we scored,” said the Italian. “I’m not happy with the first 15, 20 minutes, where we struggled. The reason why we struggled is because we prepared the game to press them man to man and the first 15, 20 minutes we were not pressing them man to man. “After 15, 20 minutes we adjust that and the game was much better. For sure we could score more but five goals they are enough.” Southampton manager Russell Martin rued a costly “moment of madness” from skipper Stephens. The defender’s ridiculous red card was the headline mistake of a catalogue of errors from the beleaguered south-coast club as they slipped seven points from safety following an 11th defeat of a dismal season. “I don’t think anyone will be as disappointed as Jack,” Martin said of Stephens, who was sent off for the second time this term after tugging the curls of Cucurella as Saints prepared to take a corner. “I haven’t got to sit down and talk with him about that at all. He will be hurt more than anyone and it’s changed the game for us tonight, which is disappointing. “I think they have to describe it as violent conduct; it’s not violent really but there’s no other explanation for that really. It’s a moment of madness that’s really cost us and Jack.” Southampton repeatedly invited pressure with their risky attempts to play out from defence, with goalkeeper Joe Lumley gifting Chelsea their second goal, scored by Nkunku. While Saints were booed off at full-time, Martin, who was missing a host of key players due to injuries and suspensions, praised the effort of his depleted team. “When they see such a big scoreline and a couple of the goals we concede, I understand it (the jeers),” he said. “It’s football, it’s emotive, people feel so much about it, it’s why it’s such a special sport in this country and so big. “I understand it but I feel really proud of the players tonight, some of the football we played at 11 v 11 was amazing. “For an hour with 10 men we’ve dug in so deep, there were some big performances. I’m proud of them for that and I’m grateful for that because that’s not easy in that circumstance.”
Walmart's DEI rollback signals a profound shift in the wake of Trump's election victoryPrime Minister Narendra Modi's Hindu nationalist party headed for a victory Saturday in state elections in politically significant Maharashtra while the opposition won mineral-rich Jharkhand state, reports The Associated Press. Polling in the two states are seen as a test of Modi's popularity after his party returned to power in June national elections but was forced to form a coalition government with help from regional partners. India's Election Commission said Modi's Bharatiya Janata Party and its allies have already won 183 of 288 seats and were leading in another 48 seats in Maharashtra, India's wealthiest state and home to the country's financial and entertainment capital, Mumbai. The opposition Congress party and its allies have won 50 of 81 seats and were leading in another four seats in eastern Jharkhand state, according to the commission. It said vote counting was nearing completion and final results were expected later on Saturday. Modi's BJP and a Hindu nationalist ally currently rule Maharashtra, where Hindus constitute nearly 80% and Muslims 11.5% of its 126 million people. An opposition alliance, including the Congress party, is in power in eastern Jharkhand state. The BJP has used slogans such as, "If you divide, then you will die," and "If we are united, then we are safe," to attract majority Hindu votes. The opposition accused it of trying to polarize voters along Hindu-Muslim religious lines. Meanwhile, Priyanka Gandhi from Congress party, the 52-year-old scion of the Nehru-Gandhi political dynasty, is set to make her debut in Parliament after winning the race against a Communist Party candidate by a huge margin of over 400,000 votes in the Wayanad seat in southern Kerala state. She contested a special election after her brother Rahul, who was elected in two constituencies in June, had to vacate one. Her mother Sonia Gandhi is already in Parliament. The BJP had hoped to attract women with a plan that provides 1,500 rupees ($18) a month to over 20 million women in the 21-65 age group whose annual family income is less than 250,000 rupees ($3,010). The Congress party promised women double that amount and free transportation in government buses. The opposition also hoped to capitalize on the simmering disaffection with high youth unemployment, inflation and low crop prices during the BJP's rule. In September, Congress was able to secure votes in India's insurgency-wracked Jammu and Kashmir after a 10-year gap. But Modi's BJP regained momentum in October and won the Haryana state election even though pollsters had predicted an easy victory for Congress. END/SZA